November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...

Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative ...

We will begin the MacroGenics 2024 third-quarter corporate progress and financial results conference call in just a moment.

Medical experts who’ve studied the experimental treatment program, however, say there’s no evidence to support Trump’s claims ...

The US could start catching up to Europe on biosimilars if the FDA removed the need for switching studies to be granted interchangeability.